Nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal said.
Nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal said Thursday.
The Medicines Patent Pool said in a statement that agreements signed with 35 companies should help make Pfizer’s antiviral nirmatrelvir, or Paxlovoid, available to more than half of the world’s population. Generic drugmakers across a dozen countries in Asia, the Caribbean, the Middle East and Eastern Europe will begin producing either the raw ingredients for the Pfizer drug or the pill itself. Among the companies offered a license was one in Ukraine, which has not yet been able to confirm it can participate.
“This will make an enormous difference for countries.” said Charles Gore, executive director of the Medicines Patent Pool. He said the availability of the Pfizer drug in some of the world's poorest countries is especially critical. “They have been at the back of the queue for vaccines, so having a treatment like this in the armory will be absolutely critical to prevent deaths.”
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Alnylam files patent infringement lawsuits against Pfizer, ModernaAlnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc , claiming their multibillion-dollar mRNA COVID-19 vaccines infringe one its patents.
Weiterlesen »
Pfizer COVID antiviral: Dozens of companies to start making pillNearly three dozen companies in Asia, the Caribbean, the Middle East and Eastern Europe will soon start making either generic versions of Pfizer's coronavirus pill or the raw ingredients. This deal will make the antiviral nirmatrelvir, or Paxlovoid, available to more than half of the world's population.
Weiterlesen »
More than 30 companies to start making Pfizer's COVID pillNearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill, the U.N.-backed Medicines Patent Pool said Thursday. That should help make Pfizer’s pill available to more than half of the world’s population.
Weiterlesen »
35 Manufacturers Granted Licenses To Produce Generic Version Of Pfizer's Covid Antiviral Pill For Developing CountriesNearly three dozen pharmaceutical companies around the world have signed agreements to produce generic versions of Pfizer’s oral Covid-19 antiviral medication nirmatrelvir.
Weiterlesen »
Sir Graham Vick: Late opera director's honour received by partnerSir Graham, who founded the Birmingham Opera Company, died in July of Covid complications.
Weiterlesen »
Pfizer's Covid vaccine safe in people with prior myocarditis, study saysThe findings of a small French study may be reassuring to those with histories of the heart condition who are reluctant to get vaccinated, experts said.
Weiterlesen »